





  The When and the How 
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1928 – Fleming discovers  
penicillin, from a fungae, 
Penicillium. 
 
1940 – Howard Florey and 
Ernst Chain made first 
therapeutic study with   
penicillin. 
Antibiotics 
End of Sec. XIX – 
Arsfenamine synthesis 





Time of antibiotics in patients 
with septic shock 
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Dosing of antibiotics to maximize the exposure of antibiotics 
to bacteria 










Effect of the antibiotic at 
















Area under the concentration curve 
MIC 





































Gomez 1999; 43:1789 
Ceftazidime 
Levofloxacin 






































Volume of Distribution 
Vd of β-Lactams in critically ill patients and healthy volunteers. 
10 20  30 40 50 60 



















 Gonçalves-Pereira. Crit Care 2011, 15: R206 
○ Vd in healthy 
volunteers 
■ Vd in critical patients 








Pharmacodynamic parameter of efficacy: Peak/MIC 











Lomaestro - Antimicrob Agents Chemother 2005  
































1 g tid (0.5-hour perfusion) 
0.5 g qid (0.5-hour perfusion) 































2 g bid (0.5-hour perfusion) 
1 g qid (0.5-hour perfusion) 
4 g continuous perfusion in the 24 h 


































Low suspition of VAP (CPIS≤6) 
Antibiotics (median) intervention 3d vs. standard 9.8d 















Time of antibiotics and Mortality 









Pneumonia Abdominal Urinary Bloodstream Surgical Catheter Other
Agressive
Conservative
Mortality 13% vs. 27%; p=0.015; AOR 2.5 (1.5-4.0) 
LOS 12.5 vs 17.7 (p=0.008) 








Can Antibiotics harm patients? 
Singer. Plos Med 2005. e167 
 May promote mitochondrial damage 
and shutdown. 
 May interfere with mitochondrial 
biogenesis and delay recovery. 
Riesbeck. Antimicrob Agents Chemother 1990, 167 
This mitochondrial toxicity may 




Riou Int J Antimicrob Agents 2010; 36:513 
Induction of Resistance 
Bacteria previously exposed to an 
antibiotic 
 




Accumulation and Toxicity 
Ceftriaxone 2 g/d 
  Accumulation in renal failure 
Cr Cl >50 mL/min <50 mL/min 
Day 1 19,5 μg/mL 46,5 μg/mL 
Day7 38,5 μg/mL 125 μg/mL 
Heinemeyer Int Care Med 1990; 16; 448 
 Betalactamin-induced central nervous side effects include 
confusion, disturbances of behaviour, hallucinations, asterixis, myoclonic 
jerks, and generalised convulsive or nonconvulsive seizures. Those are 
probably underreported but may contribute to morbidity and mortality. 




Triginer Intensive Care Med 1990;16:303-306 
Ventilator Associated Pneumonia 
  Dose of antibiotics 
Progressive normalization of PK 
• Normalization of the increase in Vd 
and Cl (with sepsis resolution) 
 




SOFA 5.5 [4.8-8.0] 3.0 [2.8-4.5] 
Vdss/Weight (L/Kg) 0.26 [0.22-0.33] 0.20 [0.15-0.30] 
Vdss (p)/Vdss (%) 71% [56%-82%] 58% [43%-70%] 
Cl (L/h) 6.8 [3.0-7.9] 6.0 [3.9-11.6] 
Trough (mg/L) 3.0 [2.7-5.8] 2.5 [1.1-6.8] 
Meropenem PK 




Critically ill septic patient 
Large Volume of Distribution 
• Large volume 
resuscitation 
• Invasive Ventilation 
• Surgical procedure 
Initial High Loading Dose 






      (measure Cr Clearance) 
• Vasopressors 
• ↑ Cardiac output 
• ↑ Diuresis 
Maintain High Dose 
Reassess after 48-72h 
Any of:  
• Bacteria with a low MIC 
• Normalization of (measured) 
Cr Clearance 
• Sepsis resolution 
Adjust Dose 
Dose modulation: A new concept 





 Initial administration of adequate 
antibiotic treatment 
  or 
 Noninfectious etiology for the 
infiltrates 
  and 
 Signs and symptoms suggesting 
active infection had resolves 
 
Micek Chest 2004;125:1791 
Discontinuation of Antibiotics 
Hospital Mortality 32%  vs. 37.1% (p=0.357) 
 Lenght of stay (H) 15.7 vs. 15.4 (p=0.865) 




O início precoce da antibioterapia deve ser restrito a situações de risco, 
em particular choque (expectativa armada) 
Os conceitos de PK/PD devem ajudar a seleccionar a posologia, 
integrados na restante avaliação clínica 
Como regra a antibioterapia pode ser limitada a um período não superior 
a 7 dias 
Os riscos de sub-dosagem por um lado e de acumulação e toxicidade 
por outro devem ser sempre ponderados e a dose modulada 
Conclusões 
A antibioterapia é sempre uma arma de dois gumes, podendo também 
causar dano no hospedeiro e interferir com a sua ecologia. 
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